Benzinga | Dec 4, 2020 08:07AM EST

Foghorn Therapeutics Q3 EPS $(3.12), Sales $179.00K

Foghorn Therapeutics (NASDAQ:FHTX) reported quarterly losses of $(3.12) per share. The company reported $179.00 thousand in sales this quarter.